Literature DB >> 7949121

Stage-specific oligonucleotide uptake in murine bone marrow B-cell precursors.

Q Zhao1, T Waldschmidt, E Fisher, C J Herrera, A M Krieg.   

Abstract

Fluorescein isothiocyanate (FITC)-conjugated phosphodiester and phosphorothioate oligonucleotides were used in four-color flow cytometry with murine bone marrow cells stained with monoclonal antibody specific for the differentiation markers B220, S7 (CD43), and BP-1 to show possible stage-specific oligonucleotide uptake. Relatively low uptake was observed among pre-Pro- and early Pro-B cells. Late Pro-B- and pre-B cells had increased oligonucleotide uptake, whereas B cells had a lower level. Cell membrane binding of oligonucleotides varied during B-cell differentiation in parallel with internalization, which was documented by confocal microscopy. An FITC-conjugated polyanionic dextran sulfate also showed differentiation-related B-cell association, suggesting the presence of cell membrane binding sites specific for polyanions as opposed to a unique feature of the DNA backbone. Interpretation of antisense experiments in murine bone marrow cells will need to account for the heterogeneous oligonucleotide uptake among differentiating B cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7949121

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  CpG-ODN 2006 and human parvovirus B19 genome consensus sequences selectively inhibit growth and development of erythroid progenitor cells.

Authors:  Yong-Mei Guo; Keiko Ishii; Makoto Hirokawa; Hiroyuki Tagawa; Hideaki Ohyagi; Yoshihiro Michishita; Kumi Ubukawa; Junsuke Yamashita; Toshiaki Ohteki; Nobuyuki Onai; Kazuyoshi Kawakami; Weiguo Xiao; Kenichi Sawada
Journal:  Blood       Date:  2010-03-26       Impact factor: 22.113

Review 2.  Flow cytometry applications in pharmacodynamics and drug delivery.

Authors:  M Ramanathan
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

3.  Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo.

Authors:  Alexander H Dalpke; Stefan Zimmermann; Inka Albrecht; Klaus Heeg
Journal:  Immunology       Date:  2002-05       Impact factor: 7.397

Review 4.  CpG DNA: a pathogenic factor in systemic lupus erythematosus?

Authors:  A M Krieg
Journal:  J Clin Immunol       Date:  1995-11       Impact factor: 8.317

5.  Immunization with a hemagglutinin-derived synthetic peptide formulated with a CpG-DNA-liposome complex induced protection against lethal influenza virus infection in mice.

Authors:  Jae Won Rhee; Dongbum Kim; Byung Kwon Park; Sanghoon Kwon; Sunhee Cho; Ilseob Lee; Man-Seong Park; Jae-Nam Seo; Yong-Sun Kim; Hong Seok Choi; Younghee Lee; Hyung-Joo Kwon
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

6.  Production of antibodies with peptide-CpG-DNA-liposome complex without carriers.

Authors:  Dongbum Kim; Sanghoon Kwon; Jae Won Rhee; Kwang Dong Kim; Young-Eun Kim; Cheung-Seog Park; Myeong Jun Choi; Jun-Gyo Suh; Doo-Sik Kim; Younghee Lee; Hyung-Joo Kwon
Journal:  BMC Immunol       Date:  2011-05-18       Impact factor: 3.615

7.  Synovial cytokine mRNA expression during arthritis triggered by CpG motifs of bacterial DNA.

Authors:  G M Deng; A Tarkowski
Journal:  Arthritis Res       Date:  2000-10-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.